Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD-SW
09618
5
BABA-W
09988
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -14.19%-2.29M | -63.96%-2.11M | -1,108.16%-3.06M | -149.09%-324.63K | 368.64%551.18K | -57.48%-2M | -329.22%-1.29M | 94.77%-253.39K | 140.84%661.25K | 77.25%-205.17K |
| Net income from continuing operations | -489.31%-7.45M | -84.77%-2.13M | -1.13%-5.82M | -0.05%-1.7M | -46.13%-1.7M | 19.34%-1.26M | 12.87%-1.15M | 77.26%-5.76M | -9.84%-1.7M | 94.21%-1.17M |
| Operating gains losses | 53.61%-85.82K | -3,152.43%-448.68K | -58.43%169.03K | -160.18%-106.69K | 321.36%446.03K | -137.79%-185K | 125.03%14.7K | -38.09%406.59K | 114.09%177.29K | 59.00%-201.49K |
| Depreciation and amortization | -5.43%459.56K | 0.87%488.45K | -0.61%1.91M | -2.48%469.26K | -1.69%472.68K | 1.24%485.95K | 0.48%484.22K | 0.94%1.92M | -0.01%481.2K | 2.22%480.79K |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | -2,910.54%-47.12K | 214.69%219.41K | 10.61%203.95K | 267.98%50.79K | 172.40%85.01K | -101.51%-1.57K | -12.74%69.72K | -21.02%184.39K | -138.07%-30.23K | 169.27%31.21K |
| Other non cashItems | 43.57%475.15K | 21.17%486.3K | 28.77%1.71M | 51.95%496.33K | 13.95%477.41K | 14.62%330.96K | 38.14%401.34K | 1,484.93%1.32M | 26.02%326.64K | 44.95%418.96K |
| Change In working capital | -12.77%-1.54M | 34.41%-723.45K | -173.76%-1.23M | -66.80%467.11K | 234.33%774.3K | -28.39%-1.37M | -201.02%-1.1M | 219.98%1.67M | 244.05%1.41M | 241.20%231.6K |
| -Change in receivables | -837.02%-1.54M | 382.76%2.32M | -160.12%-1.3M | -134.25%-398.82K | 38.82%-285.3K | 142.23%209.34K | -142.04%-821.35K | 540.13%2.16M | 264.87%1.16M | -207.13%-466.3K |
| -Change in inventory | --0 | --0 | -57.23%1.1K | 97.35%-580 | -81.75%755 | -96.92%137 | -95.05%786 | -26.04%2.57K | -3,618.49%-21.89K | --4.14K |
| -Change in prepaid assets | 754.50%58.38K | -6,716.97%-1.12M | -69.13%183.64K | 22.74%39.76K | 13.66%135.94K | -104.97%-8.92K | -93.60%16.86K | 263.23%594.83K | 113.11%32.39K | -31.33%119.6K |
| -Change in payables and accrued expense | 72.45%-238.43K | -131.30%-642.74K | -252,230.81%-499.22K | 22.77%488.11K | -65.15%156.11K | -133.27%-865.56K | 41.41%-277.88K | 100.06%198 | 1,132.95%397.59K | 174.29%447.95K |
| -Change in other working capital | 125.84%181.4K | -5,918.96%-1.29M | 135.12%382.08K | 304.49%338.64K | 507.55%766.8K | -83.77%-701.97K | 96.79%-21.39K | -406.57%-1.09M | -1,241.54%-165.6K | 174.03%126.21K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -14.19%-2.29M | -63.96%-2.11M | -1,108.16%-3.06M | -149.09%-324.63K | 368.64%551.18K | -57.48%-2M | -329.22%-1.29M | 94.77%-253.39K | 140.84%661.25K | 77.25%-205.17K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -20.88%-6.83K | 0 | 31.89%-13.88K | 0 | 0 | -5.65K | -8.23K | -133.85%-20.38K | -14,051.39%-20.38K | 0 |
| Net PPE purchase and sale | -20.88%-6.83K | --0 | 31.89%-13.88K | --0 | --0 | ---5.65K | ---8.23K | -108.13%-20.38K | -14,051.39%-20.38K | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -20.88%-6.83K | --0 | 31.89%-13.88K | --0 | --0 | ---5.65K | ---8.23K | -133.85%-20.38K | -14,051.39%-20.38K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -154.29%-96.72K | -37.53%-96.26K | -65.50%2M | 32.53%1.94M | -102.89%-47.64K | -89.51%178.16K | -107.11%-70K | 186.27%5.79M | 135.77%1.46M | 921.91%1.65M |
| Net issuance payments of debt | -152.10%-96.72K | -38.07%-95.26K | 101.08%17.57K | -41.75%-51.47K | 48.48%-47.64K | 127.29%185.66K | 91.55%-69K | -34.88%-1.63M | 98.65%-36.31K | 40.01%-92.47K |
| Net common stock issuance | ---- | ---- | -73.51%2M | 33.33%2M | --0 | --0 | --0 | 128.79%7.55M | -54.55%1.5M | --1.75M |
| Net other financing activities | --0 | 0.00%-1K | 85.80%-18.5K | -900.00%-10K | --0 | ---7.5K | ---1K | -83.62%-130.26K | ---1K | 81.17%-8.75K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -154.29%-96.72K | -37.53%-96.26K | -65.50%2M | 32.53%1.94M | -102.89%-47.64K | -89.51%178.16K | -107.11%-70K | 186.27%5.79M | 135.77%1.46M | 921.91%1.65M |
| Net cash flow | ||||||||||
| Beginning cash position | -29.70%4.4M | -13.60%6.58M | 259.53%7.61M | -10.33%4.96M | 9.73%4.46M | 72.46%6.25M | 259.53%7.61M | -56.37%2.12M | 75.75%5.53M | -4.10%4.07M |
| Current changes in cash | -30.62%-2.39M | -61.61%-2.21M | -119.49%-1.08M | -23.28%1.61M | -65.12%503.54K | -526.91%-1.83M | -188.33%-1.36M | 299.73%5.52M | 310.62%2.1M | 220.56%1.44M |
| Effect of exchange rate changes | -121.75%-8.17K | 592.64%23.54K | 262.80%40.39K | 141.40%7.36K | -142.43%-7.94K | 214.95%37.57K | 109.03%3.4K | -186.93%-24.81K | 38.32%-17.78K | -81.87%18.7K |
| End cash Position | -55.20%2M | -29.70%4.4M | -13.60%6.58M | -13.60%6.58M | -10.33%4.96M | 9.73%4.46M | 72.46%6.25M | 259.53%7.61M | 259.53%7.61M | 75.75%5.53M |
| Free cash from | -14.21%-2.29M | -62.91%-2.11M | -1,023.30%-3.08M | -150.65%-324.63K | 368.64%551.18K | -57.92%-2.01M | -330.69%-1.29M | 94.36%-273.77K | 139.58%640.87K | 77.25%-205.17K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.